Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A multi-stem cell basis for craniosynostosis and calvarial mineralization. | Nature | 2023 | 37730988 | PubTator, text mining | PubMed |
| Extracellular matrix-induced signaling pathways in mesenchymal stem/stromal cells. | Cell Commun Signal | 2023 | 37726815 | PubTator, text mining | PubMed |
| Phase separation and pathologic transitions of RNP condensates in neurons: implications for amyotrophic lateral sclerosis, frontotemporal dementia and other neurodegenerative disorders. | Front Mol Neurosci | 2023 | 37720552 | PubTator, text mining | PubMed |
| Focusing on the Native Matrix Proteins in Calcific Aortic Valve Stenosis. | JACC Basic Transl Sci | 2023 | 37719438 | PubTator, text mining | PubMed |
| Impact of ramucirumab plus erlotinib on circulating cell-free DNA from patients with untreated metastatic non-small cell lung cancer with EGFR-activating mutations (RELAY phase 3 randomized study). | Transl Lung Cancer Res | 2023 | 37691865 | PubTator, text mining | PubMed |
| Real-Time Evaluation of Thyroid Cytology Using New Digital Microscopy Allows for Sample Adequacy Assessment, Morphological Classification, and Supports Molecular Analysis. | Cancers (Basel) | 2023 | 37686491 | PubTator, text mining | PubMed |
| The Dual Role of Mesenchymal Stem Cells in Cancer Pathophysiology: Pro-Tumorigenic Effects versus Therapeutic Potential. | Int J Mol Sci | 2023 | 37686315 | PubTator, text mining | PubMed |
| The Influence of Race/Ethnicity on the Transcriptomic Landscape of Uterine Fibroids. | Int J Mol Sci | 2023 | 37686244 | PubTator, text mining | PubMed |
| Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors. | Science | 2023 | 37676964 | PubTator, text mining | PubMed |
| Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix. | Front Immunol | 2023 | 37662958 | PubTator, text mining | PubMed |
| Mutation status analysis of 58 patients with advanced ALK fusion gene positive non small cell lung cancer. | BMC Pulm Med | 2023 | 37658352 | PubTator, text mining | PubMed |
| How many kinases are druggable? A review of our current understanding. | Biochem J | 2023 | 37642371 | PubTator, text mining | PubMed |
| Efficient Lung Cancer Molecular Diagnostics by Combining Next Generation Sequencing with Reflex Idylla Genefusion Assay Testing. | Genes (Basel) | 2023 | 37628603 | PubTator, text mining | PubMed |
| Acquired resistance to anti-PD1 therapy in patients with NSCLC associates with immunosuppressive T cell phenotype. | Nat Commun | 2023 | 37620318 | PubTator, text mining | PubMed |
| [Application of precision-cut lung slice technology to study the role of DDR2 in pulmonary fibrosis]. | Sheng Li Xue Bao | 2023 | 37583038 | PubTator, text mining | PubMed |
| Sophoridine derivative 6j inhibits liver cancer cell proliferation via ATF3 mediated ferroptosis. | Cell Death Discov | 2023 | 37580343 | PubTator, text mining | PubMed |
| Mesodermal Derivatives of Pluripotent Stem Cells Route to Scarless Healing. | Int J Mol Sci | 2023 | 37569321 | PubTator, text mining | PubMed |
| Breast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Turning the Magnifying Glass on Rare and Aggressive Entities. | Cancers (Basel) | 2023 | 37568749 | PubTator, text mining | PubMed |
| Environmental Determinants of Ferroptosis in Cancer. | Cancers (Basel) | 2023 | 37568677 | PubTator, text mining | PubMed |
| Update in Lung Cancer Molecular Pathology: Technological Advances and Clinical Practice. | Cancers (Basel) | 2023 | 37568629 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=12